Jan. 23, 2020—Using part of an antibody isolated at Vanderbilt that “broadly neutralizes” the human dengue virus, biologists at the University of California San Diego and colleagues have disarmed the mosquito that transmits the disabling and potentially deadly tropical infection.
Dec. 1, 2016—In a new study, Vanderbilt pharmacologist Jerod Denton, Ph.D., Ohio State entomologist Peter Piermarini, Ph.D., and colleagues report an experimental molecule that inhibits kidney function in mosquitoes and thus might provide a new way to control the deadliest animal on Earth.
Jul. 8, 2015—In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States.
Nov. 27, 2014—Vanderbilt biologists played an important supporting role in a major genetic study of malaria-carrying mosquitoes published this week in the journal "Science."
May. 31, 2013—Researchers are targeting a possible new weapon in the fight against malaria, science that could also be applied in the fight against other devastating mosquito-borne illnesses, according to a Vanderbilt study published in PLOS ONE.
Jul. 30, 2012—Hot and humid temperatures across the Southeast may have people feeling lethargic, but conditions are perfect for active ticks and mosquitos. Insects are out in abundance and reaping the benefits from a mild winter and an early spring. As a result, pediatricians with the Monroe Carell Jr. Children’s Hospital at Vanderbilt are experiencing a significant...